ANDROPATCH Itàlia - italià - AIFA (Agenzia Italiana del Farmaco)

andropatch

sanol medicinali s.r.l. - testosterone - testosterone

TESTOMED Itàlia - italià - AIFA (Agenzia Italiana del Farmaco)

testomed

mibe pharma italia s.r.l. - testosterone - testosterone

TESTOVIRON Itàlia - italià - AIFA (Agenzia Italiana del Farmaco)

testoviron

gmm farma s.r.l. - testosterone - testosterone

Firmagon Unió Europea - italià - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.